OVID: Ovid Therapeutics Inc. Stock

by  •  • Comments Off on OVID: Ovid Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 20.40
Enterprise Value ($M) -5.90
Book Value ($M) 68.23
Book Value / Share 0.96
Price / Book 0.30
NCAV ($M) 32.00
NCAV / Share 0.45
Price / NCAV 0.64

Profitability (mra)
Return on Invested Capital (ROIC) -0.32
Return on Assets (ROA) -0.20
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 5.32
Current Ratio 5.32

Balance Sheet (mrq) ($M)
Current Assets 55.94
Assets 92.17
Liabilities 23.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.57
Operating Income -61.88
Net Income -26.43
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -55.96
Cash from Investing 54.59
Cash from Financing 0.62

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Madison Avenue Partners, LP 4.00 -21.82
11-14 13G/A Biotechnology Value Fund L P 5.40 -43.75
11-14 13G/A EcoR1 Capital, LLC 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-15 105,334 198,591 53.04
2025-04-14 26,470 315,181 8.40
2025-04-11 65,389 294,293 22.22
2025-04-10 146,046 410,823 35.55

(click for more detail)

Similar Companies
OPK – OPKO Health, Inc. OPTN – OptiNose, Inc.
ORIC – ORIC Pharmaceuticals, Inc. PBYI – Puma Biotechnology, Inc.
PCRX – Pacira BioSciences, Inc.


Financial data and stock pages provided by
Fintel.io